POSTER: AML-132 QuANTUM-First Trial: FLT3–Internal Tandem Duplication (FLT3-ITD)–Specific Measurable Residual Disease (MRD) Clearance Is Associated With Improved Overall Survival (OS)

Clinical Lymphoma, Myeloma & Leukemia(2023)

引用 0|浏览9
暂无评分
关键词
acute myeloid leukemia,FLT3-ITD,measurable residual disease,NGS,PCR,quizartinib,phase III
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要